Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.3K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.3K
Vaccinations01:51

Vaccinations

53.7K
Overview
53.7K
Vaccines01:21

Vaccines

42
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
42
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

1.6K
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Immunological Memory01:23

Immunological Memory

17.9K
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
17.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac dysfunction in medulloblastoma survivors treated with photon irradiation.

Neuro-oncology practice·2022
Same author

Abnormal Vital Sign Recognition and Provider Notification in the Pediatric Emergency Department.

Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners·2020
Same author

Fibromatosis Colli: A Case Report.

Advanced emergency nursing journal·2020
Same author

Transition to the tenure track for nurse faculty with young children: a case study.

Nursing education perspectives·2012
Same journal

Parental childhood vaccination hesitancy and refusal in Türkiye: A systematic review of contributing factors.

Journal of pediatric nursing·2026
Same journal

The effect of sticker intervention on children's pain and anxiety after invasive procedures.

Journal of pediatric nursing·2026
Same journal

Addressing Pediatric COVID-19 Vaccine Hesitancy through Community Engagement: A Descriptive Evaluation of the VaxUpPhillyFamilies program.

Journal of pediatric nursing·2026
Same journal

Associations between healthy lifestyle belief among adolescents their sociodemographic characteristics and parental healthy life education conscious level.

Journal of pediatric nursing·2026
Same journal

A clinical pathway for young adults with medical complexity in a pediatric emergency department.

Journal of pediatric nursing·2026
Same journal

The effect of psychological resilience on caregiver burden among parents of children with special needs: The mediating role of internalized stigma.

Journal of pediatric nursing·2026
See all related articles

Related Experiment Video

Updated: Mar 30, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K

Human Papillomavirus Infection and Vaccination.

Katie Valentino1, Cathlin B Poronsky1

  • 1Loyola University Chicago, IL.

Journal of Pediatric Nursing
|November 21, 2015
PubMed
Summary
This summary is machine-generated.

Human papillomavirus (HPV) vaccination rates are below recommendations due to barriers like lack of provider endorsement. Stronger provider recommendations are key to increasing HPV vaccine uptake and preventing HPV-related cancers.

Keywords:
AdolescentsEfficacyHPVHuman papillomavirusImmunizationInfectionParent attitudesSafetyVaccination barriersVaccineVaccine deliveryYoung adults

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K

Related Experiment Videos

Last Updated: Mar 30, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

13.1K
RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

28.4K
Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
06:57

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis

Published on: June 14, 2019

11.5K

Area of Science:

  • Immunology
  • Public Health
  • Vaccinology

Background:

  • Human papillomavirus (HPV) is a common sexually transmitted infection linked to genital warts and various cancers.
  • Two vaccines, Gardasil® and Cervarix™, are available for HPV prevention.
  • Despite vaccine availability, HPV immunization rates in the US remain suboptimal.

Purpose of the Study:

  • To identify facilitators and barriers to HPV vaccine utilization and series completion among females in the US.
  • To discuss HPV infection, vaccine safety, and efficacy.
  • To explore strategies for improving HPV immunization rates and implications for healthcare providers.

Main Methods:

  • A comprehensive literature review was conducted using major health-related online databases.
  • Archival searching was employed to gather data on vaccination rates and uptake factors.
  • The review focused on identifying current vaccination trends and influencing elements.

Main Results:

  • HPV vaccine acceptance and utilization rates are lower than recommended by the Advisory Committee for Immunization Practices (ACIP).
  • Key barriers include insufficient provider recommendations, negative parental/patient attitudes, cost, and missed opportunities for vaccination.
  • A strong provider recommendation emerged as the most significant facilitator for HPV vaccination.

Conclusions:

  • Healthcare providers play a crucial role in enhancing HPV vaccine utilization.
  • Strategies such as patient education, advocacy, maximizing vaccine access, and innovative delivery methods can improve immunization rates.
  • Active provider engagement is essential for overcoming barriers and promoting HPV vaccination.